I guess the highlights are:
- discussions with potential partners for trof ex-NA progressing, with strong interest received from multiple parties
- Revised Angelman syndrome protocol has been submitted to FDA, Phelan-McDermid and Pitt Hopkins protocols to be submitted shortly
Ann: Q4 2021 quarterly activity and cash flow report, page-3
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.72 |
Change
-0.030(0.22%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.46 | $4.275M | 312.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 370 | $13.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.72 | 311 | 11 |
View Market Depth
| Last trade - 14.34pm 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |